Boyd Steven

10% OwnerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Jun 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
24
12 non-derivative · 12 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 28, 2021Option exercise(X)676K3.7M
Jun 28, 2021Option exercise(X)1.5M1.6M
Jun 28, 2021Option exercise(X)0$01.6M
Jun 28, 2021Option exercise(X)1.5M3.1M
Jun 28, 2021Option exercise(X)0$03.7M
Jun 28, 2021Option exercise(X)676K4.4M
Jun 28, 2021Option exercise(X)0$04.4M
Jun 28, 2021Option exercise(X)2.3M6.7M
Jun 28, 2021Option exercise(X)0$06.7M
Jun 28, 2021Option exercise(X)564K7.2M
Jun 28, 2021Option exercise(X)0$07.2M
Jun 28, 2021Option exercise(X)0$03.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 28, 2021Option exercise(X)1.5M0
Jun 28, 2021Option exercise(X)00
Jun 28, 2021Option exercise(X)1.5M0
Jun 28, 2021Option exercise(X)564K0
Jun 28, 2021Option exercise(X)00
Jun 28, 2021Option exercise(X)2.3M0
Jun 28, 2021Option exercise(X)00
Jun 28, 2021Option exercise(X)676K0
Jun 28, 2021Option exercise(X)00
Jun 28, 2021Option exercise(X)676K0
Jun 28, 2021Option exercise(X)00
Jun 28, 2021Option exercise(X)00

Transaction Codes

X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-21-004321) within minutes of acceptance. Every field above traces to the original document. Verify it directly: